Screener
ImmunityBio, Inc. IBRX Reportable Segment — SG&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other research and development costs | 8,469 | 6,466 |
| Total internal research and development expense | 47,907 | 42,723 |
| Total research and development expense (including amounts with related parties) | 67,989 | 48,234 |
| Selling, general and administrative (including amounts with related parties) | 45,770 | 32,654 |
| Total operating expenses | 113,759 | 80,888 |
| Loss from operations | (69,791) | (64,429) |
| Other income (expense), net | ||
| Interest and investment income, net | 2,314 | 887 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s reportable segment — SG&A?
- ImmunityBio, Inc. (IBRX) reported reportable segment — SG&A of $45.77M in Q1 2026.
- How has ImmunityBio, Inc.'s reportable segment — SG&A changed year-over-year?
- ImmunityBio, Inc.'s reportable segment — SG&A increased by 40.2% year-over-year, from $32.65M to $45.77M.
- What is the long-term trend for ImmunityBio, Inc.'s reportable segment — SG&A?
- Over 3 years (2022 to 2025), ImmunityBio, Inc.'s reportable segment — SG&A has grown at a 13.5% compound annual growth rate (CAGR), from $102.71M to $150M.
- What does reportable segment — SG&A mean?
- Includes all non-research operating expenses such as marketing, legal, executive compensation, and general office overhead. These costs support the administrative and commercial infrastructure of the segment.
Ask your AI about ImmunityBio, Inc.'s reportable segment — sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude